elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58793525-4E2ED3AF-9111-4B96-8DE5-EBDCE10BD71D
Q58793525-4E2ED3AF-9111-4B96-8DE5-EBDCE10BD71D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58793525-4E2ED3AF-9111-4B96-8DE5-EBDCE10BD71D
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
P2860
Q58793525-4E2ED3AF-9111-4B96-8DE5-EBDCE10BD71D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58793525-4E2ED3AF-9111-4B96-8DE5-EBDCE10BD71D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc167dd514dad1a8d9a8426fc64d8e3f6cda606c
P2860
Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.